The COX-2-1195AA Genotype Is Associated with Diffuse-Type Gastric Cancer in Korea

被引:21
|
作者
Shin, Woon Geon [1 ]
Kim, Ha Jung [2 ]
Cho, Sung Jin [3 ]
Kim, Hyoung Su [1 ]
Kim, Kyung Ho [1 ]
Jang, Myoung Kuk [1 ]
Lee, Jin Heon [1 ]
Kim, Hak Yang [1 ]
机构
[1] Hallym Univ, Coll Med, Dept Internal Med, Seoul 134701, South Korea
[2] Hallym Univ, Coll Med, Lab Study Gastroenterol & Hepatol, Seoul 134701, South Korea
[3] Hallym Univ, Coll Med, Dept Pathol, Seoul 134701, South Korea
关键词
Stomach neoplasms; Diffuse type; COX-2; Polymorphism; HELICOBACTER-PYLORI INFECTION; E-CADHERIN GENE; ATROPHIC GASTRITIS; CYCLOOXYGENASE-2; EXPRESSION; INTESTINAL METAPLASIA; GERMLINE MUTATIONS; INCREASED RISK; POLYMORPHISMS; CARCINOGENESIS; INTERLEUKIN-1;
D O I
10.5009/gnl.2012.6.3.321
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: The potential role of the cyclooxygenase (COX)-2 polymorphism has been reported in relation to the risk of gastrointestinal tract malignancies. Therefore, we investigated whether COX-2 polymorphisms are associated with the risk of gastric cancer (GC) in Korea, one of the areas with a high prevalence of this condition. Methods: We evaluated the genotypic frequencies of COX-2-765 and -1195 in 100 peptic ulcer patients, 100 GC patients, and 100 healthy controls. The polymorphisms of the COX-2-765 and -1195 genes were analyzed by polymerase chain reaction and restriction fragment length polymorphisms. Results: The frequencies of the COX-2-1195 GG, GA, and AA genotype were 20%, 60%, and 20% in intestinal-type GC and 8%, 48%, and 44% in diffuse-type GC, respectively (p=0.021). There were no significant differences in the frequency of COX-2-765 genotypes between intestinal-type GC and diffuse-type GC (p=0.603). Age- and sex-adjusted logistic regression analysis showed that the COX-2-1195 AA genotype was the independent risk factor of diffuse-type GC compared with the COX-2-1195 GG genotype (p=0.041; odds ratio, 6.22; 95% confidence interval, 1.077 to 35.870). Conclusions: The COX-2-1195 M genotype may render subjects more susceptible to diffuse-type GC. (Gut Liver 2012;6:321-327)
引用
收藏
页码:321 / 327
页数:7
相关论文
共 50 条
  • [41] GASTRIC PRE-CANCEROUS LESIONS AND DIFFUSE-TYPE GASTRIC CANCER: A META-ANALYSIS
    Wang, John E.
    Huang, Robert J.
    GASTROINTESTINAL ENDOSCOPY, 2021, 93 (06) : AB336 - AB337
  • [42] Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer
    Ascaño, JJ
    Frierson, H
    Moskaluk, CA
    Harper, JC
    Roviello, F
    Jackson, CE
    El-Rifai, W
    Vindigni, C
    Tosi, P
    Powell, SM
    MODERN PATHOLOGY, 2001, 14 (10) : 942 - 949
  • [43] A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors
    Fukamachi, Hiroshi
    Kim, Seon-Kyu
    Koh, Jiwon
    Lee, Hye Seung
    Sasaki, Yasushi
    Yamashita, Kentaro
    Nishikawaji, Taketo
    Shimada, Shu
    Akiyama, Yoshimitsu
    Byeon, Sun-ju
    Bae, Dong-Hyuck
    Okuno, Keisuke
    Nakagawa, Masatoshi
    Tanioka, Toshiro
    Inokuchi, Mikito
    Kawachi, Hiroshi
    Tsuchiya, Kiichiro
    Kojima, Kazuyuki
    Tokino, Takashi
    Eishi, Yoshinobu
    Kim, Yong Sung
    Kim, Woo Ho
    Yuasa, Yasuhito
    Tanaka, Shinji
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38
  • [44] Whole-genome analysis of a mouse model of diffuse-type gastric cancer
    Zhang, Menghua
    Sugita, Itsuki
    Komura, Daisuke
    Katoh, Hiroto
    Ishikawa, Shumpei
    CANCER SCIENCE, 2021, 112 : 606 - 606
  • [45] Differences in genomic instability between intestinal- and diffuse-type gastric cancer
    Vauhkonen M.
    Vauhkonen H.
    Sajantila A.
    Sipponen P.
    Gastric Cancer, 2005, 8 (4) : 238 - 244
  • [46] Evolutionary History of the Risk of SNPs for Diffuse-Type Gastric Cancer in the Japanese Population
    Iwasaki, Risa L.
    Ishiya, Koji
    Kanzawa-Kiriyama, Hideaki
    Kawai, Yosuke
    Gojobori, Jun
    Satta, Yoko
    GENES, 2020, 11 (07) : 1 - 19
  • [47] SERPINE1 Intron Polymorphisms Affecting Gene Expression Are Associated With Diffuse-Type Gastric Cancer Susceptibility
    Ju, Hyoungseok
    Lim, Byungho
    Kim, Minjin
    Noh, Seung-Moo
    Kim, Woo Ho
    Ihm, Chunhwa
    Choi, Bo Youl
    Kim, Yong Sung
    Kang, Changwon
    CANCER, 2010, 116 (18) : 4248 - 4255
  • [48] A Regulatory Polymorphism at Position-309 in PTPRCAP Is Associated with Susceptibility to Diffuse-type Gastric Cancer and Gene Expression
    Ju, Hyoungseok
    Lim, Byungho
    Kim, Minjin
    Kim, Yong Sung
    Kim, Woo Ho
    Ihm, Chunhwa
    Noh, Seung-Moo
    Han, Dong Soo
    Yu, Hang-Jong
    Choi, Bo Youl
    Kang, Changwon
    NEOPLASIA, 2009, 11 (12): : 1340 - 1347
  • [49] Phase 2 trial of defactinib in combination with avutometinib in patients with advanced diffuse-type gastric cancer.
    Moy, Ryan H.
    Wu, Lawrence Wen
    Cho, Hope
    Wang, Shikun
    Ana, Sarah Sta
    Strickland, Matthew
    Sender, Naomi
    Klempner, Samuel J.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : TPS505 - TPS505
  • [50] Clinical significance of diffuse-type histological type coexistence in Stage II/III gastric cancer
    Tanaka, Hiroaki
    Muguruma, Kazuya
    Tamura, Tatsuro
    Toyokawa, Takahiro
    Shibutani, Masatsune
    Fukuoka, Tatsunari
    Nagahara, HIsashi
    Ohira, Masaichi
    CANCER RESEARCH, 2019, 79 (13)